Thursday, April 24th, 2025

Optimax Holdings: Eyeing Steady Growth with Strong Market Position

Date of Report: October 25, 2024
Broker: CGS International


Overview

Optimax Holdings Berhad is a Malaysian healthcare company specializing in providing eye care services. It operates a network of eye specialist centers across Malaysia, offering a range of services, including cataract surgeries, LASIK, and general eye care. Optimax has established itself as a leading player in the eye care industry, catering to a growing demand for vision correction and eye health services.

Stock Performance

Optimax Holdings is currently listed as a “Buy” in CGS International’s actively managed portfolio. The stock was last traded at RM0.665, reflecting a slight decline from its entry price of RM0.695. Despite the dip, the company remains a part of the portfolio due to its solid fundamentals and market position.

Technical Indicators

  • Entry Price: RM0.695
  • Current Price: RM0.665
  • Stop Loss: RM0.630
  • Target Prices: RM0.77, RM0.795
  • Position: BUY
  • Profit/Loss: -4.3%

Recent Performance Analysis

Optimax’s stock has seen a decline of 4.3% from its entry price, currently trading at RM0.665. While the stock has faced some short-term challenges, the company continues to focus on expanding its service offerings and reaching more customers across Malaysia. Its strong market presence and consistent service delivery are key factors driving its long-term potential.

Investment Strategy

CGS International advises maintaining a buy position for Optimax Holdings, with target prices set at RM0.77 and RM0.795. The recommended stop-loss is at RM0.630, which acts as a risk management measure. Optimax’s ongoing efforts to expand its network of eye care centers and introduce new treatments are expected to support future growth.

Analyst Commentary

CGS International remains optimistic about Optimax Holdings’ long-term growth prospects, emphasizing the company’s strategic initiatives to enhance its service offerings and geographic reach. Although there has been a minor dip in the stock price, the overall market dynamics and Optimax’s leadership in the eye care sector suggest the potential for recovery and further gains. Investors seeking exposure to the healthcare sector, particularly eye care services, may find Optimax Holdings to be a solid addition to their portfolio.


Source: CGS International Trendspotter, October 25, 2024.

SIA Engineering Q3 Results: Steady Recovery Amid Supply Chain Challenges | 4.5% Dividend Yield

Detailed Analysis of SIA Engineering Company Ltd by UOB Kay Hian Comprehensive Analysis of SIA Engineering Company Ltd Broker Name: UOB Kay Hian Date of Report: February 17, 2025 SIA Engineering Company Ltd (SIE...

Sapura Energy’s Q3 Results: PLSV Recovery and FCF Potential Signal Turnaround

Sapura Energy Bhd: A Deep Dive into Financial Performance and Strategic Outlook Sapura Energy Bhd: A Deep Dive into Financial Performance and Strategic Outlook By UOB Kay Hian | Dated: 13 December 2024 Introduction...

The Erawan Group: New Hotel Project – Growth Opportunity or Financial Burden?

The Erawan Group: An In-Depth Financial Analysis The Erawan Group: An In-Depth Financial Analysis Date: December 6, 2024 Broker: UOB Kay Hian Company Overview The Erawan Group, a leading hotel investment company in Thailand,...